GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CERENOME, INC. (CNSY) | 8/14/2026 4:55:20 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $411,000 -70.4% | Assets $14,030,000 | EPS -$1.31 | |
| CERENOME, INC. (CNSY) | 8/14/2026 4:31:54 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $411,000 -70.4% | Assets $14,030,000 | EPS -$1.31 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 5/15/2026 4:45:28 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $1,028,000 -2.9% | Assets $19,916,000 | EPS -$1.05 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 5/15/2026 4:22:03 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $1,028,000 -2.9% | Assets $19,916,000 | EPS -$1.05 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 3/31/2026 4:38:22 PM | View | Proxy | SEC | Y 2025 | ||||||
| PLUS THERAPEUTICS, INC. (CNSY) | 3/12/2026 4:45:14 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $5,213,000 -10.5% | Assets $16,325,000 | EPS -$0.29 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 3/12/2026 4:25:05 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $1,367,000 -3.2% | Assets $16,325,000 | Export Earnings Model | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 10/30/2025 4:34:51 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $1,397,000 -4.1% | Assets $18,670,000 | EPS -$0.04 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 10/30/2025 4:17:06 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $1,397,000 -4.1% | Assets $18,670,000 | EPS -$0.04 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 8/14/2025 4:36:37 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $1,390,000 +8.7% | Assets $10,350,000 | EPS -$0.01 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 8/14/2025 4:15:12 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $1,390,000 +8.7% | Assets $10,350,000 | EPS -$0.01 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 7/21/2025 4:08:43 PM | View | Proxy | SEC | Y 2024 | ||||||
| PLUS THERAPEUTICS, INC. (CNSY) | 5/30/2025 4:24:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $1,059,000 -36.9% | Assets $12,056,000 | EPS -$1.19 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 5/30/2025 4:21:52 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $1,059,000 -36.9% | Assets $12,056,000 | EPS -$1.19 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 4/30/2025 4:12:32 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Rev: $5,824,000 +18.5% | Assets $6,633,000 | EPS -$2.34 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 4/10/2025 4:15:31 PM | View | Proxy | SEC | Y 2024 | ||||||
| PLUS THERAPEUTICS, INC. (CNSY) | 3/31/2025 4:16:55 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $5,824,000 +18.5% | Assets $6,633,000 | EPS -$2.34 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 3/27/2025 4:25:14 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $1,412,000 +7.5% | Assets $6,633,000 | EPS -$0.67 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 11/14/2024 4:15:08 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $1,456,000 +17.4% | Assets $6,978,000 | EPS -$0.37 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 11/14/2024 4:14:46 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $1,456,000 +17.4% | Assets $6,978,000 | EPS -$0.37 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 8/14/2024 4:45:58 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $1,279,000 -31.0% | Assets $11,212,000 | EPS -$0.71 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 8/14/2024 4:09:29 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $1,279,000 -31.0% | Assets $11,212,000 | EPS -$0.71 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 7/10/2024 7:01:34 AM | View | Proxy | SEC | Y 2023 | ||||||
| PLUS THERAPEUTICS, INC. (CNSY) | 5/15/2024 4:17:31 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $1,677,000 +231.4% | Assets $5,621,000 | EPS -$0.75 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 5/15/2024 4:05:32 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $1,677,000 +231.4% | Assets $5,621,000 | EPS -$0.75 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 3/5/2024 4:20:43 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $4,913,000 +2,093.3% | Assets $11,388,000 | EPS -$4.24 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 3/5/2024 4:06:31 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $1,313,000 +769.5% | Assets $11,388,000 | EPS -$0.70 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 10/31/2023 4:15:45 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $1,240,000 +1,598.6% | Assets $13,278,000 | EPS -$1.00 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 10/31/2023 4:08:35 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $1,240,000 +1,598.6% | Assets $13,278,000 | EPS -$1.00 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 8/14/2023 4:22:55 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $1,854,000 | Assets $14,197,000 | EPS -$0.59 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 8/14/2023 4:16:06 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $1,854,000 | Assets $14,197,000 | EPS -$0.59 | |
| Plus Therapeutics, Inc. (CNSY) | 5/30/2023 7:01:28 AM | View | Financials | Earnings | WIRE | 1Q 2023 | Rev $506,000 | Assets $15,638,000 | EPS -$2.07 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 4/20/2023 4:11:39 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $506,000 | Assets $15,638,000 | EPS -$2.07 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 4/20/2023 4:06:32 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $506,000 | Assets $15,638,000 | EPS -$2.07 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 3/7/2023 4:45:49 PM | View | Proxy | SEC | Y 2022 | ||||||
| PLUS THERAPEUTICS, INC. (CNSY) | 2/23/2023 4:20:38 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $224,000 | Assets $23,867,000 | EPS -$11.58 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 2/23/2023 4:14:01 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $151,000 | Assets $23,867,000 | EPS -$2.36 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 10/20/2022 4:35:23 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $73,000 | Assets $23,104,000 | EPS -$2.85 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 10/20/2022 4:20:23 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $73,000 | Assets $23,104,000 | EPS -$2.85 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 7/21/2022 4:18:05 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $21,271,000 | EPS -$3.56 | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 7/21/2022 4:11:58 PM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $21,271,000 | EPS -$3.56 | Export Earnings Model | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 4/21/2022 4:19:24 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $24,516,000 | EPS -$0.19 | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 4/21/2022 4:12:13 PM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $24,516,000 | EPS -$0.19 | Export Earnings Model | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 4/7/2022 5:02:05 PM | View | Proxy | SEC | Y 2021 | ||||||
| PLUS THERAPEUTICS, INC. (CNSY) | 2/24/2022 4:28:51 PM | View | Financials | Earnings | SEC | Y 2021 | Assets $21,981,000 | EPS -$0.27 | Export Earnings Model | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 2/24/2022 4:23:27 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $21,981,000 | EPS -$1.11 | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 10/21/2021 4:18:56 PM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $24,750,000 | EPS -$0.28 | Export Earnings Model | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 10/21/2021 4:15:00 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $24,750,000 | EPS -$0.28 | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 7/22/2021 4:22:10 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $20,834,000 | EPS -$0.25 | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 7/22/2021 4:08:09 PM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $20,834,000 | EPS -$0.25 | Export Earnings Model | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 4/22/2021 4:12:19 PM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $18,336,000 | EPS -$0.33 | Export Earnings Model | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 4/22/2021 4:11:30 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $18,336,000 | EPS -$0.33 | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 4/5/2021 5:04:15 PM | View | Proxy | SEC | Y 2020 | ||||||
| PLUS THERAPEUTICS, INC. (CNSY) | 2/22/2021 4:28:33 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $0 | Assets $12,105,000 | EPS -$0.73 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 2/22/2021 4:23:53 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $303,000 -95.7% | Assets $12,105,000 | EPS -$1.86 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 10/22/2020 4:18:48 PM | View | Financials | Earnings | SEC | 3Q 2020 | Assets $11,653,000 | EPS -$0.39 | Export Earnings Model | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 10/22/2020 4:12:30 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $11,653,000 | EPS -$0.39 | ||
| PLUS THERAPEUTICS, INC. (CNSY) | 8/10/2020 6:34:21 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $185,000 -38.7% | Assets $13,904,000 | EPS -$0.45 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 8/10/2020 6:26:40 AM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $185,000 -38.7% | Assets $13,904,000 | EPS -$0.45 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 5/14/2020 4:21:14 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $118,000 -84.0% | Assets $20,967,000 | EPS -$0.28 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 5/14/2020 4:15:14 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $118,000 -84.0% | Assets $20,967,000 | EPS -$0.28 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 5/13/2020 6:17:14 AM | View | Proxy | SEC | Y 2019 | ||||||
| PLUS THERAPEUTICS, INC. (CNSY) | 3/30/2020 4:14:38 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $6,998,000 +134.6% | Assets $23,229,000 | EPS -$8.27 | |
| PLUS THERAPEUTICS, INC. (CNSY) | 3/30/2020 4:13:43 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $1,188,000 +66.6% | Assets $23,229,000 | EPS $14.48 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 11/14/2019 4:25:33 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $4,771,000 +950.9% | Assets $25,715,000 | EPS -$0.03 | |
| Plus Therapeutics, Inc. (CNSY) | 11/14/2019 4:10:39 PM | View | Financials | Earnings | WIRE | 3Q 2019 | Rev $4,771,000 +950.9% | Assets $25,715,000 | EPS -$0.03 | Export Earnings Model | |
| Plus Therapeutics, Inc. (CNSY) | 8/15/2019 7:22:02 PM | View | Financials | Earnings | WIRE | 2Q 2019 | Rev $302,000 -66.4% | Assets $8,884,000 | EPS -$20.67 | Export Earnings Model | |
| PLUS THERAPEUTICS, INC. (CNSY) | 8/15/2019 5:44:20 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $302,000 -66.4% | Assets $8,884,000 | EPS -$20.67 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/14/2019 5:11:00 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $737,000 -19.6% | Assets $24,616,000 | EPS -$8.92 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/14/2019 4:52:48 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $737,000 -19.6% | Assets $24,616,000 | EPS -$8.92 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 4/19/2019 6:03:27 AM | View | Proxy | SEC | Y 2018 | ||||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 4/1/2019 8:11:54 AM | View | Financials | Earnings | SEC | Y 2018 | Rev $713,000 +7.7% | Assets $23,991,000 | EPS $5.42 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/29/2019 8:18:31 AM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $2,983,000 +10.9% | Assets $23,991,000 | EPS -$86.98 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/14/2018 5:07:21 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $454,000 -2.8% | Assets $25,532,000 | EPS -$27.63 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/14/2018 5:00:17 PM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $454,000 -2.8% | Assets $25,532,000 | EPS -$27.63 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/14/2018 5:00:47 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $899,000 -7.2% | Assets $22,677,000 | EPS -$29.67 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/14/2018 4:50:16 PM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $899,000 -7.2% | Assets $22,677,000 | EPS -$29.67 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/11/2018 5:14:26 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $917,000 +55.2% | Assets $26,642,000 | EPS -$36.63 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/10/2018 4:55:50 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $917,000 +55.2% | Assets $26,642,000 | EPS -$36.63 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 4/6/2018 4:57:08 PM | View | Proxy | SEC | Y 2017 | ||||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/9/2018 5:02:18 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $2,689,000 -42.2% | Assets $31,615,000 | EPS -$411.60 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/8/2018 4:33:49 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $662,000 -54.8% | Assets $31,615,000 | EPS -$0.20 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/9/2017 5:13:41 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $467,000 -36.1% | Assets $26,446,000 | EPS -$1.39 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/9/2017 4:43:57 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $467,000 -36.1% | Assets $26,446,000 | EPS -$1.39 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/11/2017 5:25:10 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $969,000 -13.9% | Assets $32,476,000 | EPS -$1.94 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/10/2017 4:30:28 PM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $969,000 -13.9% | Assets $32,476,000 | EPS -$1.94 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/12/2017 5:36:27 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $591,000 -55.7% | Assets $29,771,000 | EPS -$0.33 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/11/2017 4:30:22 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $591,000 -55.7% | Assets $29,771,000 | EPS -$0.33 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 4/10/2017 5:11:13 PM | View | Proxy | SEC | Y 2016 | ||||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/24/2017 5:08:54 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $4,656,000 -3.8% | Assets $34,609,000 | EPS -$1.28 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/23/2017 5:01:12 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $1,466,000 -5.8% | Assets $34,609,000 | EPS -$0.24 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/9/2016 5:16:25 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $731,000 -4.6% | Assets $36,842,000 | EPS -$0.26 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/9/2016 4:40:08 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $731,000 -4.6% | Assets $36,842,000 | EPS -$0.26 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/5/2016 4:03:44 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $1,126,000 -30.2% | Assets $42,680,000 | EPS -$0.43 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/4/2016 4:29:20 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $1,126,000 -30.2% | Assets $42,680,000 | EPS -$0.43 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/10/2016 4:41:13 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $1,333,000 +47.8% | Assets $32,915,000 | EPS -$0.41 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/10/2016 4:30:38 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $1,333,000 +47.8% | Assets $32,915,000 | EPS -$0.41 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/15/2016 4:14:10 PM | View | Proxy | SEC | Y 2015 | ||||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/11/2016 5:02:21 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $4,838,000 -2.3% | Assets $37,698,000 | EPS -$2.07 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/3/2016 4:30:22 PM | View | Financials | Earnings | SEC | Y 2015 | Rev $1,556,000 -37.0% | Assets $37,698,000 | EPS -$0.25 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/6/2015 5:00:57 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $766,000 +47.9% | Assets $42,446,000 | EPS $0.15 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/5/2015 4:42:21 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $766,000 +47.9% | Assets $42,446,000 | EPS $0.15 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/10/2015 5:08:50 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $1,614,000 +72.6% | Assets $46,524,000 | EPS $0.45 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/6/2015 4:22:33 PM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $1,614,000 +72.6% | Assets $46,524,000 | EPS $0.45 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 7/2/2015 4:54:48 PM | View | Proxy | SEC | Y 2014 | ||||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/11/2015 5:00:40 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $902,000 -12.5% | Assets $37,046,000 | EPS -$3.19 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/11/2015 4:37:59 PM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $902,000 -12.5% | Assets $37,046,000 | EPS -$3.19 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/16/2015 4:06:02 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $4,953,000 -30.5% | Assets $38,719,000 | EPS -$0.48 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/12/2015 4:48:52 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $2,469,000 -8.8% | Assets $38,719,000 | EPS -$0.08 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/4/2015 4:58:19 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $2,469,000 -8.8% | Assets $38,719,000 | EPS -$0.08 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/4/2015 6:02:03 AM | View | Financials | Earnings | SEC | Y 2014 | Rev $2,469,000 -8.8% | Assets $38,719,000 | EPS -$0.08 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/24/2014 2:20:55 PM | View | Proxy | SEC | Y 2013 | ||||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/7/2014 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $518,000 -67.9% | Assets $32,314,000 | EPS -$0.12 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/6/2014 4:15:30 PM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $518,000 -67.9% | Assets $32,314,000 | EPS -$0.12 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/11/2014 4:48:49 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $935,000 -33.6% | Assets $38,250,000 | EPS -$0.15 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/11/2014 4:15:27 PM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $935,000 -33.6% | Assets $38,250,000 | EPS -$0.15 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 6/11/2014 5:31:21 PM | View | Proxy | SEC | Y 2013 | ||||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/12/2014 4:18:57 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $1,031,000 -25.9% | Assets $39,422,000 | EPS -$0.14 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/12/2014 4:06:09 PM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $1,031,000 -25.9% | Assets $39,422,000 | EPS -$0.14 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/14/2014 5:23:20 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $7,122,000 -18.2% | Assets $42,060,000 | EPS -$0.39 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/11/2014 4:06:16 PM | View | Financials | Earnings | SEC | Y 2013 | Rev $2,706,000 -31.8% | Assets $42,060,000 | EPS -$0.14 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/12/2013 4:08:41 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $1,616,000 +23.0% | Assets $35,222,000 | EPS -$0.08 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/7/2013 4:07:32 PM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $1,616,000 +23.0% | Assets $35,222,000 | EPS -$0.08 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/9/2013 5:01:14 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $1,408,000 -27.7% | Assets $39,764,000 | EPS -$0.05 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/8/2013 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2013 | Rev $1,408,000 -27.7% | Assets $39,764,000 | EPS -$0.05 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 7/19/2013 4:10:13 PM | View | Proxy | SEC | Y 2012 | ||||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/10/2013 4:39:37 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $1,392,000 -6.0% | Assets $33,366,000 | EPS -$0.11 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/9/2013 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2013 | Rev $1,392,000 -6.0% | Assets $33,366,000 | EPS -$0.11 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/15/2013 5:07:32 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $8,709,000 +9.1% | Assets $43,250,000 | EPS -$0.55 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/7/2013 12:00:00 AM | View | Financials | Earnings | SEC | Y 2012 | Rev $3,967,000 +91.1% | Assets $43,250,000 | EPS -$0.06 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/9/2012 4:10:58 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $1,314,000 -38.4% | Assets $32,010,000 | EPS -$0.19 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/8/2012 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2012 | Rev $1,314,000 -38.4% | Assets $32,010,000 | EPS -$0.19 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 9/7/2012 4:50:32 PM | Micro | View | Financials | 10-K/A | SEC | Y 2011 ending: 12/31/2011 | Rev: $7,983,000 -3.3% | Assets $51,534,000 | EPS -$0.61 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/9/2012 3:50:21 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $1,947,000 -19.2% | Assets $40,504,000 | EPS -$0.13 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/8/2012 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2012 | Rev $1,947,000 -19.2% | Assets $40,504,000 | EPS -$0.13 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/10/2012 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $1,481,000 +8.7% | Assets $49,102,000 | EPS -$0.16 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/9/2012 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2012 | Rev $1,481,000 +8.7% | Assets $49,102,000 | EPS -$0.16 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 4/30/2012 5:05:06 PM | View | Proxy | SEC | Y 2011 | ||||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/13/2012 5:08:23 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $7,983,000 -3.3% | Assets $51,534,000 | EPS -$0.61 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/8/2012 12:00:00 AM | View | Financials | Earnings | SEC | Y 2011 | Rev $2,076,000 -12.7% | Assets $51,534,000 | EPS -$0.13 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/8/2011 3:43:58 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $2,134,000 +40.5% | Assets $55,568,000 | EPS -$0.15 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/3/2011 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2011 | Rev $2,134,000 +40.5% | Assets $55,568,000 | EPS -$0.15 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/9/2011 4:45:47 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $2,411,000 +15.3% | Assets $48,756,000 | EPS -$0.10 | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/9/2011 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2011 | Rev $2,411,000 +15.3% | Assets $48,756,000 | EPS -$0.10 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/5/2011 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2011 | Rev $1,362,000 | EPS -$0.23 | Export Earnings Model | ||
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/2/2011 4:08:07 PM | View | Proxy | SEC | Y 2010 | ||||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/10/2011 12:00:00 AM | View | Financials | Earnings | SEC | Y 2010 | Rev $2,378,000 | Assets $66,347,000 | EPS -$0.20 | Export Earnings Model | |
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/4/2010 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2010 | Rev $1,519,000 | EPS -$0.23 | Export Earnings Model | ||
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/6/2010 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2010 | Rev $2,091,000 | EPS -$0.12 | Export Earnings Model | ||
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/6/2010 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2010 | Export Earnings Model | ||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 4/30/2010 4:09:38 PM | View | Proxy | SEC | Y 2009 | ||||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/12/2010 12:00:00 AM | View | Financials | Earnings | SEC | Y 2009 | Export Earnings Model | ||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 11/9/2009 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2009 | Export Earnings Model | ||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 8/10/2009 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2009 | Export Earnings Model | ||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 5/11/2009 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2009 | Export Earnings Model | ||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 4/30/2009 3:49:59 PM | View | Proxy | SEC | Y 2008 | ||||||
| CYTORI THERAPEUTICS, INC. (CNSY) | 3/6/2009 12:00:00 AM | View | Financials | Earnings | SEC | Y 2008 | Export Earnings Model |